ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 271 filers reported holding ACCELERON PHARMA INC in Q2 2021. The put-call ratio across all filers is 1.70 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $8,000 | -50.0% | 47 | -63.8% | 0.00% | -33.3% |
| Q2 2021 | $16,000 | -15.8% | 130 | -7.8% | 0.00% | -25.0% |
| Q1 2021 | $19,000 | -17.4% | 141 | -22.5% | 0.00% | -20.0% |
| Q4 2020 | $23,000 | +9.5% | 182 | -3.7% | 0.01% | -16.7% |
| Q3 2020 | $21,000 | +61.5% | 189 | -21.2% | 0.01% | +100.0% |
| Q4 2019 | $13,000 | +30.0% | 240 | -8.4% | 0.00% | -40.0% |
| Q3 2019 | $10,000 | 0.0% | 262 | +9.2% | 0.01% | +25.0% |
| Q2 2019 | $10,000 | – | 240 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co IV LLC | 3,133,234 | $124,076,000 | 82.43% |
| Deer VII & Co. Ltd. | 1,105,964 | $39,417,000 | 9.51% |
| Foresite Capital Management I, LLC | 66,000 | $2,614,000 | 2.54% |
| QVT Financial LP | 556,574 | $21,592,000 | 1.27% |
| Orbimed Advisors | 2,117,648 | $83,859,000 | 1.23% |
| SPHERA FUNDS MANAGEMENT LTD. | 50,000 | $1,980,000 | 0.55% |
| WALL STREET ASSOCIATES | 93,800 | $3,714,000 | 0.30% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 197,219 | $7,810,000 | 0.28% |
| EAM Investors, LLC | 37,871 | $1,500,000 | 0.27% |
| Granite Point Capital Management, L.P. | 30,000 | $1,188,000 | 0.20% |